Skip to main content


Fig. 7 | BMC Cancer

Fig. 7

From: Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma

Fig. 7

Effects of experimental CASC9 overexpression or downregulation on cell migration and chemosensitivity. Migration capacity of CASC9 overexpressing FADU (a) and HaCaT cells (b) and UM-SCC14A cells with CASC9 knockdown (c) compared to controls was measured by wound healing assay at given times points. Relative scratch width was normalized to 1 for the starting point of measurements. (d-f) Chemosensitivity was determined by MTT assay 72 h after treatment with the indicated doses of cisplatin

Back to article page